Dr. Bruce Feinberg, President and CEO of Georgia Cancer Specialists, was again recognized as a national oncology expert with a recent appearance in The New York Times.
The article, written by Andrew Pollack, ran in the May 20 edition on the front page of the business section.
In the story, Dr. Feinberg comments on the success of a recent clinical trial that may provide insight into a new approach to treating cancer.
In the trial, Avastin, a drug that blocks tumors’ access to oxygen and nutrients, was found to prolong the lives of patients with colorectal cancer.
Dr. Feinberg and Georgia Cancer Specialists were the only private oncologist or practice to appear in the article.